Next Article in Journal
Novel Computerized Method for Measurement of Retinal Vessel Diameters
Previous Article in Journal / Special Issue
The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
Article Menu

Export Article

Open AccessReview
Biomedicines 2017, 5(1), 11; doi:10.3390/biomedicines5010011

Viroimmunotherapy for Colorectal Cancer: Clinical Studies

Beckman Research Institute, City of Hope National Medical Center, Duarte 91010, CA, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Zong Sheng Guo and David L. Bartlett
Received: 1 February 2017 / Accepted: 2 March 2017 / Published: 10 March 2017
(This article belongs to the Special Issue Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer)
View Full-Text   |   Download PDF [679 KB, uploaded 11 March 2017]   |  

Abstract

Colorectal cancer is a leading cause of cancer incidence and death. Therapies for those with unresectable or recurrent disease are not considered curative at present. More effective and less toxic therapies are desperately needed. Historically, the immune system was thought to be an enemy to oncolytic viral therapy. Thinking that oncolysis would be the only mechanism for cell death, oncolytic virologists theorized that immune clearance was a detriment to oncolysis. Recent advances in our understanding of the tumor microenvironment, and the interplay of tumor survival and a patient’s immune system have called into question our understanding of both arenas. It remains unclear what combination of restrictions or enhancements of innate and/or cell-mediated immunity can yield the highest likelihood of viral efficacy. This article reviews the variety of mechanisms explored for viruses such as immunotherapy for colorectal cancer. View Full-Text
Keywords: oncolytic virus; colorectal cancer; immunotherapy; viral gene therapy oncolytic virus; colorectal cancer; immunotherapy; viral gene therapy
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Chaurasiya, S.; Warner, S. Viroimmunotherapy for Colorectal Cancer: Clinical Studies. Biomedicines 2017, 5, 11.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Biomedicines EISSN 2227-9059 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top